Avidity Biosciences, Inc.'s innovative AOC platform and promising clinical programs make it a high-risk, high-reward ...

We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we ...

A breakthrough in safely delivering therapeutic DNA to cells could transform treatment for millions suffering from common ...

Mouse cells tweaked to produce the tardigrade protein incurred less DNA damage than unaltered cells — hinting at a new tool for cancer patient care.

We recently published a list of 10 Stocks with Potential to Explode in 2025. In this article, we are going to take a look at ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

The research field of "cellular IRESes" lay dormant for decades, as there was no uniform standard of reliable methods for the clear characterization of these starting points for the ribosome-mediated ...

Tom Lee managing partner and head of research at Fundstrat Global Advisors appeared on a CNBC interview to talk about how the ...

Nucleic Acid Production revenue was $41.9 million for the fourth quarter, representing a 28.8% decrease year-over-year. The revenue decrease was primarily from large GMP orders in 2023 not recurring ...

Short sellers increased their bets against the broader healthcare sector in February vs. January, and Moderna remained the ...

Citi said SMid biotech sentiment has been more challenged than expected in early 2025, largely due to investor focus on ...

According to NFL insider Field Yates, the contracts of quarterback Patrick Mahomes and defensive tackle Chris Jones were restructured to free up $49.446M in cap space for the team. The specifics ...